MBOT

Microbot Medical Inc

MBOT, USA

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

https://microbotmedical.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MBOT
stock
MBOT

Microbot Medical is a buy, Roth says Cantech Letter

Read more →
MBOT
stock
MBOT

Microbot Medical (NASDAQ:MBOT) Earns Buy Rating from Analysts at Roth Capital MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$12

Analyst Picks

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Low

1.48

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-4.57 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-4.38 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very High

0.05

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 14.73% of the total shares of Microbot Medical Inc

1.

Vanguard Group Inc

(4.2269%)

since

2025/06/30

2.

Vanguard Total Stock Mkt Idx Inv

(2.9579%)

since

2025/07/31

3.

Atlantic Trust Group, LLC

(1.2615%)

since

2025/06/30

4.

Geode Capital Management, LLC

(0.8143%)

since

2025/06/30

5.

Vanguard Institutional Extnd Mkt Idx Tr

(0.7301%)

since

2025/07/31

6.

BlackRock Inc

(0.662%)

since

2025/06/30

7.

DnB NOR Asset Management (Asia)

(0.3974%)

since

2025/06/30

8.

DNB Fund - Disruptive Opp Retail A EUR

(0.3974%)

since

2025/07/31

9.

Fidelity Extended Market Index

(0.3625%)

since

2025/07/31

10.

Morgan Stanley - Brokerage Accounts

(0.3252%)

since

2025/06/30

11.

State Street Corp

(0.2855%)

since

2025/06/30

12.

AlphaCentric Robotics and Automation I

(0.2577%)

since

2025/06/30

13.

Extended Equity Market Fund K

(0.168%)

since

2025/06/30

14.

iShares Micro-Cap ETF

(0.1652%)

since

2025/08/31

15.

Fidelity Total Market Index

(0.1563%)

since

2025/07/31

16.

Northern Trust Corp

(0.1465%)

since

2025/06/30

17.

Two Sigma Investments LLC

(0.1421%)

since

2025/06/30

18.

Fidelity Series Total Market Index

(0.0938%)

since

2025/07/31

19.

LPL Financial Corp

(0.0916%)

since

2025/06/30

20.

Spartan Extended Market Index Pool F

(0.0867%)

since

2025/07/31

21.

UBS Group AG

(0.0856%)

since

2025/06/30

22.

Northern Trust Extended Eq Market Idx

(0.0768%)

since

2025/06/30

23.

NT Ext Equity Mkt Idx Fd - L

(0.0768%)

since

2025/06/30

24.

Goldman Sachs Group Inc

(0.0701%)

since

2025/06/30

25.

Hilltop Holdings Inc

(0.0694%)

since

2025/06/30

26.

NT Ext Equity Mkt Idx Fd - NL

(0.0681%)

since

2025/06/30

27.

Fidelity Nasdaq Composite Index

(0.0663%)

since

2025/07/31

28.

Susquehanna International Group, LLP

(0.0656%)

since

2025/06/30

29.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0528%)

since

2025/06/30

30.

Spartan Total Market Index Pool G

(0.0474%)

since

2025/07/31

31.

Scotia Capital Inc

(0.0469%)

since

2025/06/30

32.

Vanguard U.S. Eq Idx £ Acc

(0.0412%)

since

2025/07/31

33.

XTX Topco Ltd

(0.0354%)

since

2025/06/30

34.

Stifel Financial Corp

(0.0332%)

since

2025/06/30

35.

Beacon Capital Management, LLC

(0.033%)

since

2025/06/30

36.

Avantis US Small Cap Equity ETF

(0.032%)

since

2025/08/30

37.

Citigroup Inc

(0.0289%)

since

2025/06/30

38.

American Century Companies Inc

(0.0262%)

since

2025/06/30

39.

State St US Extended Mkt Indx NL Cl C

(0.0249%)

since

2025/08/31

40.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0217%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.04

Latest Release

Date

2025-09-30

EPS Actual

-0.07

EPS Estimate

-0.08

EPS Difference

0.01

Surprise Percent

12.5%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(0.5)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.